Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health

Key Points:

·The American tobacco companies Altria and Reynolds American have launched new smokeless products without receiving FDA marketing authorization. 

·Anti-smoking advocates are concerned that these unauthorized products could attract new customers and potentially harm the health of adolescents.

According to a report from richmond on August 31, 2025, American tobacco companies Altria and Reynolds American are dissatisfied with the delayed approval of new tobacco products by the US FDA. They plan to launch smokeless alternatives without waiting for official FDA marketing authorization.

Altria and Reynolds both stated that the FDA gained jurisdiction over tobacco and nicotine products in 2009 under federal law, but has not made approval decisions within the legally prescribed time frame. At the same time, these companies pointed out that illegal e-cigarettes, due to their unknown ingredients and candy flavors appealing to young people, are quickly gaining market share, while many companies' legal products have been awaiting approval for a long time.

The FDA stated that all new tobacco products must receive approval before being sold in the US market, but as of August 31, only 39 e-cigarette products and 20 nicotine pouch products have been approved. However, Altria's subsidiary Helix plans to launch a new version of "on!" nicotine pouch in North Carolina, Texas, and Florida starting in the fall of 2025.

A spokesperson for Altria revealed that the company submitted a pre-market tobacco product application to the FDA in June 2024, and has met all regulatory requirements. They stated that the FDA's approval process is significantly exceeding the statutory 180-day timeline, which is severely impacting the company's market progress for their products.

At the same time, Reynolds plans to launch a new disposable e-cigarette called "Vuse One" in the fourth quarter of 2025 in South Carolina, Florida, and Georgia to advance the process of reducing tobacco harm.

Concerns have been raised by anti-smoking advocates regarding these actions. Smokeless tobacco products are often accused of attracting new customers, and the FDA's efforts to prevent youth smoking seem insufficient. Dave Lemmon of the Campaign for Tobacco-Free Kids pointed out that moves by companies like Altria and Reynolds appear to be bold introductions of unauthorized products to the market.